Genetics
COVID-19 mutations and their links to excessive immune responses
Mutations on a key SARS-CoV-2 viral protein are linked to extreme immune responses and could offer a novel vaccine target.
Sep 27, 2023
0
18
Page 34 - News tagged with replication
Diseases, Conditions, Syndromes
New drug combination offers hope to patients with currently untreatable Hepatitis C
Hepatitis C is a viral infection which, if left untreated, can lead to severe and potentially fatal liver damage. Existing treatments consist of a combination of drugs, usually ribavirin, pegylated interferon and a protease ...
Nov 5, 2013
0
0
Oncology & Cancer
Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors
Two recent papers from researchers in the Children's Hospital of Philadelphia (CHOP) Cancer Center have advanced the understanding of treatment-resistant pediatric tumors, both in assessing a novel treatment and in characterizing ...
Apr 27, 2023
0
65
Oncology & Cancer
Making glioblastoma more vulnerable to treatment
In the tough war against glioblastoma, scientists are taking a cue from viruses on how to make the aggressive cancer more vulnerable to treatment.
Nov 1, 2022
0
32
Diseases, Conditions, Syndromes
A practicable and reliable therapeutic strategy to treat SARS-CoV-2 infection
In a new study in Cell Discovery, Chen-Yu Zhang's group at Nanjing University and two other groups from Wuhan Institute of Virology and the Second Hospital of Nanjing present a novel finding that absorbed miRNA MIR2911 in ...
Jul 28, 2020
0
7
Medications
Chemically modified plant compounds work against hepatitis E virus
Hepatitis E virus (HEV) is widespread, and so far there is no effective drug to treat it. In the search for one, the so-called rocaglates have come into focus: plant compounds that can inhibit the replication of viruses. ...
Jun 27, 2022
0
3
Genetics
Newly discovered interactions between proteins can reduce DNA damage and cancer development
Researchers at the Karolinska Institutet have discovered a new interaction between two proteins that reduce the risk of DNA damage and cellular cancer development. The findings on the proteins RTEL1 and Poldip3 are published ...
Jun 18, 2020
0
0
HIV & AIDS
Texas Biomed files patent for a novel HIV vaccine strategy
The Texas Biomedical Research Institute in San Antonio has applied for a patent for a genetically-engineered vaccine strategy to prevent HIV infection that targets the outer layers of body structures that are the first sites ...
Nov 19, 2012
0
0
Medical research
Cytomegalovirus hijacks human enzyme for replication
More than 60 percent of the world's population is infected with a type of herpes virus called human cytomegalovirus. The virus replicates by commandeering the host cell's metabolism but the details of this maneuver are unclear.
Mar 23, 2015
0
8
Oncology & Cancer
Engineering a cancer-fighting virus
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical ...
Jan 29, 2019
0
5
